Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Effect of Intravenous and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy (IOE Study)

NCT01142245 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT01142245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01142245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Effect of Intravenous and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy (IOE Study)
Lead sponsor
Chinese University of Hong Kong
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2008
Completion date
July 31, 2014
Enrollment
263 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, peptic ulcer